Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for hospitalized patients with COVID-19 pneumonia
IRCT20110423006257N3Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia comparing Thalidomide + standard of care with Placebo + standard of care (2 arms). Primary endpoints: Duration of hospitalization, Death rate and 3 more. Started Apr 2021; status: completed.
02
Drugs
thalidomide
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20110423006257N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110423006257N3.